GlassScriptPhysician profile
Paul C Thur
NPI 1801895073
$3,349.32
in general payments reported to CMS, 2019-2025
37 companies · $884 in 2025
The $884 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $202 · 2021: $616 · 2022: $676 · 2023: $458 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,341.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $692.84 | 2020-2022 | |
| Procept Biorobotics Corporation | $424.65 | 2023-2025 | Aquabeam Robotic System |
| Teleflex LLC | $342.83 | 2021-2023 | Urolift |
| Calyxo, INC. | $248.15 | 2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $216.35 | 2019-2021 | |
| Neotract INC. | $165.80 | 2019-2020 | |
| Stryker Corporation | $165.67 | 2025 | 1788 |
| Boston Scientific Corporation | $158.74 | 2021 | |
| Endo Pharmaceuticals INC. | $126.84 | 2019-2021 | |
| Pfizer INC. | $66.27 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.50 | 2019-2021 | |
| Janssen Biotech, INC. | $48.60 | 2020-2025 | Rybrevant, Carvykti |
| Bioprotect Medical, INC. | $44.64 | 2025 | Bioprotect Balloon Implant System |
| Tolmar Pharmaceuticals, INC. | $43.12 | 2019-2021 | |
| Antares Pharma, INC. | $43.01 | 2019-2025 | Xyosted |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $40.90 | 2021 | |
| Abbvie INC. | $35.96 | 2019-2021 | |
| Amgen INC. | $34.14 | 2019-2021 | |
| Dentsply Ih Ab | $30.46 | 2021-2023 | Lofric |
| Clarus Therapeutics INC. | $30.04 | 2021 | |
| Urogen Pharma, INC. | $29.47 | 2025 | |
| Davol INC. | $26.77 | 2021 | |
| Coloplast Corp | $25.80 | 2019-2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $24.06 | 2019 | |
| Valencia Technologies Corporation | $23.50 | 2025 | Ecoin Device Kit |
| Rochester Medical Corporation | $22.65 | 2021 | |
| Axonics, INC. | $22.02 | 2021 | |
| Dendreon Pharmaceuticals LLC | $19.21 | 2020 | |
| Endo USA, INC. | $18.44 | 2025 | Xiaflex, Aveed |
| Novartis Pharmaceuticals Corporation | $17.63 | 2025 | |
| Urovant Sciences INC | $14.97 | 2021 | |
| Blue Earth Diagnostics | $14.95 | 2019 | |
| Foundation Medicine, INC. | $14.86 | 2020 | |
| Allergan, INC. | $13.94 | 2021 | |
| Myovant Sciences INC. | $13.71 | 2021 | |
| Aytu Biopharma, INC. | $13.57 | 2019 | |
| Photocure INC | $12.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Thur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.